Science Explorer Back to mapMap

Most cited papers from Heron Therapeutics (United States)

What are the most cited papers from Heron Therapeutics (United States)?

The most cited paper from Heron Therapeutics (United States) is "Applying Model Based Systems Engineering (MBSE) to a standard CubeSat" (Sara Spangelo, David Kaslow, Christopher L. Delp et al., 2012), with 107 citations. Next come "Cost-Effectiveness Analyses of Natalizumab (Tysabri®) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK" (103) and "Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review" (90).

Showing 50 of 69 papers. Every paper with more than 1 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Applying Model Based Systems Engineering (MBSE) to a standard CubeSat Sara Spangelo, David Kaslow, Christopher L. Delp et al. Conference paper Mar 2012 107
2 Cost-Effectiveness Analyses of Natalizumab (Tysabri®) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK Ray Gani, Gavin Giovannoni, David O. Bates et al. · PharmacoEconomics 2008 103
3 Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review Kristien Van Acker, Philippe Léger, Agnès Hartemann et al. · Diabetes/Metabolism Research and Reviews Review 27 Jan 2014 90
4 Food chain analysis of exposures and risks to wildlife at a metals-contaminated wetland Gary A. Pascoe, Richard J. Blanchet, G. Linder · Archives of Environmental Contamination and Toxicology Mar 1996 59
5 Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain Thomas Ottoboni, Barry D. Quart, Jayne Pawasauskas et al. · Regional Anesthesia & Pain Medicine Open access 16 Dec 2019 56
6 HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: phase III results from the randomized EPOCH 1 study Eugene R. Viscusi, Joseph S Gimbel, Richard A Pollack et al. · Regional Anesthesia & Pain Medicine Open access 21 May 2019 54
7 HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study Eugene R. Viscusi, Harold S. Minkowitz, Peter J. Winkle et al. · Hernia Open access 19 Aug 2019 51
8 Discharge of methylmercury-enriched hypolimnetic water from a stratified reservoir C.M Canavan · The Science of The Total Environment 9 Oct 2000 44
9 Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients Chad M. Brummett, Jackie Evans-Shields, Christina England et al. · Journal of Managed Care & Specialty Pharmacy Open access 24 Feb 2021 40
10 Integrating data types to estimate spatial patterns of avian migration across the Western Hemisphere Timothy D. Meehan et al. · Ecological Applications Open access 19 May 2022 39
11 Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron Thomas Ottoboni, Mark Gelder, Erin O’Boyle · Journal of Experimental Pharmacology Open access Dec 2014 39
12 HTX-011 Reduced Pain and Opioid Use After Primary Total Knee Arthroplasty: Results of a Randomized Phase 2b Trial Paul F. Lachiewicz, Gwo‐Chin Lee, Richard A. Pollak et al. · The Journal of Arthroplasty Open access 27 May 2020 33
13 Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery Chad M. Brummett, Christina England, Jackie Evans-Shields et al. · Journal of Managed Care & Specialty Pharmacy Open access 17 Jul 2019 33
14 Observations of the suppression of tide-generated nonlinear internal wave packets in the Strait of Gibraltar Pavel Pistek, Paul E. La Violette · Journal of Marine Systems Apr 1999 26
15 APF530 (Granisetron Injection Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy Ian D. Schnadig, Richy Agajanian, Christopher S. R. Dakhil et al. · Future Oncology Open access 21 Mar 2016 25
16 Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation Thomas Ottoboni, Mary Rose Keller, Matt Cravets et al. · Drug Design Development and Therapy Open access 28 Feb 2018 23
17 Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects Tom Ottoboni, Michael Lauw, Mary Rose Keller et al. · Future Oncology Open access 6 Jun 2018 22
18 Let’s Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine Laura LaNiel Tenner, Fay J. Hlubocky, Charles David Blanke et al. · Journal of Oncology Practice Open access 2019 20
19 Opioid-free recovery after herniorrhaphy with HTX-011 as the foundation of a multimodal analgesic regimen Neil Singla, Peter J. Winkle, Todd Bertoch et al. · Surgery Open access 14 Sep 2020 19
20 A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer Growth Nilotpal Roy et al. · Cancer Discovery Open access 19 Dec 2025 18
21 Inducing positive emotional state in Intelligent Tutoring Systems Soumaya Chaffar, Lotfi Derbali, Claude Frasson · Frontiers in artificial intelligence and applications Book chapter 2009 18
22 Hypersensitivity and Infusion-Site Adverse Events with Intravenous Fosaprepitant after Anthracycline-Containing Chemotherapy: A Retrospective Study Ralph Vincent Boccia, Robert B. Geller, Neil J. Clendeninn et al. · Future Oncology Open access 10 Oct 2018 17
23 Worksite Temperature Screening for COVID-19 Gregg M. Stave, Sharon E. Smith, Pamela A. Hymel et al. · Journal of Occupational and Environmental Medicine Open access 28 Apr 2021 16
24 An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin Sunny Lyn Sneed, Brian B. Reese, Ana Fs Laureano et al. · Journal of Clinical Investigation Open access 14 Feb 2024 15
25 Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma Michael D. Jenkinson, Trevor Smith, Brian J. Haylock et al. · Journal of Neuro-Oncology 9 Jan 2010 15
26 Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapy Lee Steven Schwartzberg, Trent McLaughlin, Robert B. Geller et al. · Journal of Comparative Effectiveness Research Open access 11 Oct 2018 12
27 HTX-019 via 2-Min Injection or 30-Min Infusion in Healthy Subjects Thomas Ottoboni, Michael Lauw, Mary Rose Keller et al. · Future Oncology Open access 21 Dec 2018 11
28 Opioid-Free Recovery After Hernia Repair with HTX-011 as the Foundation of a Non-Opioid, Multimodal Analgesia Regimen in a Real-World Setting: A Randomized, Open-Label Study Harold S. Minkowitz, Roy G. Soto, John R. Fanikos et al. · Pain and Therapy Open access 27 Jul 2021 10
29 Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015 William J. Bodell, Donald D. Giannini, Saira Singh et al. · Journal of Neuro-Oncology May 2003 10
30 HTX-011 Effectively Reduces Postoperative Pain Intensity and Opioid use in the Elderly Tina Yip, Jia Hu, Pamela S Hawn et al. · Pain Management Open access 21 Jul 2021 9
31 APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial Ian D. Schnadig, Richy Agajanian, Christopher S. R. Dakhil et al. · Cancer Management and Research Open access May 2017 8
32 In-Vehicle Validation of Heavy-Duty Vehicle Fuel Savings via a Hierarchical Predictive Online Controller Evan Pelletier, Wushuang Bai, Miguel Alvarez Tiburcio et al. · SAE International Journal of Advances and Current Practices in Mobility 6 Apr 2021 7
33 Identifying habitat correlates of latent occupancy when apparent annual occupancy is confounded with availability for detection Seth M. Harju, Scott M. Cambrin · Biological Conservation Open access Oct 2019 7
34 Real-world effectiveness of palonosetron-based antiemetic regimens: preventing chemotherapy-induced nausea and vomiting Lee Steven Schwartzberg, Stanley M. Marks, Nashat Y. Gabrail et al. · Journal of Comparative Effectiveness Research Open access 9 May 2019 7
35 Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse Amaal Jilani Starling, Roger K. Cady, Dawn C. Buse et al. · The Journal of Headache and Pain Open access 26 Feb 2024 6
36 HTX-011 in Combination with Multimodal Analgesic Regimen Minimized Severe Pain and Opioid Use after Total Knee Arthroplasty in an Open-Label Study Gwo‐Chin Lee, Richard D. Berkowitz, Scott A. Hacker et al. · The Journal of Knee Surgery Open access 10 Jun 2022 4
37 Comparative detection, density, and reproductive performance of Kirtland's warbler in jack and red pine Fred Van Dyke, Seth M. Harju, Michael Hindy et al. · Journal of Wildlife Management 14 Apr 2022 4
38 Length of hospital stay after vaginal hysterectomy Guthrie Rankin · BJOG An International Journal of Obstetrics & Gynaecology Feb 1995 4
39 Indirect impacts of a highway on movement behavioral states of a threatened tortoise and implications for landscape connectivity Seth M. Harju, Scott M. Cambrin, Jodi Berg · Scientific Reports Open access 6 Jan 2024 3
40 Grazing by an endemic atyid shrimp controls microbial communities in the Hawaiian anchialine ecosystem Justin C. Havird, Pamela M. Brannock, Reyn M. Yoshioka et al. · Limnology and Oceanography Open access 13 Jul 2022 3
41 Signaling Under Stress: Targeting the Glucocorticoid Receptor in Cancer Melanie S. Flint, David M. O’Malley, Domenica Lorusso et al. · Cancer Research Open access 18 May 2026 2
42 Glucobovoside A Viqar Uddin Ahmad, Anwer Basha Book chapter 2006 2
43 Stability of Aprepitant Injectable Emulsion in Alternate Infusion Bags, in Refrigerated Storage, and Admixed with Dexamethasone and Palonosetron Thomas Ottoboni, Laura E. Lerner, Arlene Santhouse · Drug Design Development and Therapy Open access Jun 2021 2
44 Phase 3 trial of APF530 vs. ondansetron, each with a neurokinin 1 antagonist and corticosteroid, for prevention of chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy regimens (MAGIC Trial): Outcomes in cisplatin-based regimen L. S. Schwartzberg, Michael C. Mosier, Yetunde Payne et al. · Gynecologic Oncology Jun 2016 2
45 Predicting Stress Level Variation from Learner Characteristics and Brainwaves Alicia Heraz, Jraidi Imène, Maher Chaouachi et al. · Frontiers in artificial intelligence and applications Book chapter 2009 2
46 Development and validation of an LC-MS/MS method for the quantification of novel therapeutic TT-478, a selective adenosine receptor 2B antagonist, for a phase I/II clinical trial Daniel E. Whitaker, Laura Francis, Sami Karaborni et al. · Bioanalysis Open access 2 Sep 2025 1
47 High‐resolution remote sensing for quantifying vegetation structure as avian habitat Seth M. Harju, Tarita Harju, Jodi Berg et al. · Wildlife Society Bulletin Open access 10 Feb 2025 1
48 Bird communities of jack pine and red pine stand types in Michigan: Implications of multi- versus single-species management Fred Van Dyke, Seth M. Harju, Michael Hindy et al. · The Wilson Journal of Ornithology Sep 2023 1
49 Cynanformoside A Viqar Uddin Ahmad, Anwer Basha Book chapter 2006 1
50 Oxystine Viqar Uddin Ahmad, Anwer Basha Book chapter 2006 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.